18 May 2013
Keywords: pharmamar, reports, progress, yondelis, soft, tissue, sarcoma
Article | 09 January 2006
Spain's PharmaMar says that the independent data monitoring committee for the pivotal trial of Yondelis (trabectedin) in soft tissue sarcoma
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 January 2006
17 May 2013
© 2013 thepharmaletter.com